abstract |
The present invention relates to polypeptidesncontaining cytomegalovirus (CMV) specific AD2 sequences,nwhich sequence from at least two homologous regionsnthe N-terminal region of the glycoprotein gp116, which is characterized by thenGen encoded UL55 include, and their use innDiagnostics, prophylaxis and therapy. |